nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—DRD1—Parkinson's disease	0.263	0.325	CbGaD
Acepromazine—HTR1A—Parkinson's disease	0.219	0.27	CbGaD
Acepromazine—DRD2—Parkinson's disease	0.186	0.229	CbGaD
Acepromazine—HTR2A—Parkinson's disease	0.144	0.177	CbGaD
Acepromazine—HTR2A—enteric nervous system—Parkinson's disease	0.00574	0.0744	CbGeAlD
Acepromazine—DRD1—telencephalic ventricle—Parkinson's disease	0.00461	0.0598	CbGeAlD
Acepromazine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00435	0.0564	CbGeAlD
Acepromazine—HTR2A—locus ceruleus—Parkinson's disease	0.00379	0.0492	CbGeAlD
Acepromazine—HTR2A—cerebellar cortex—Parkinson's disease	0.00309	0.0401	CbGeAlD
Acepromazine—HTR1A—telencephalic ventricle—Parkinson's disease	0.00302	0.0391	CbGeAlD
Acepromazine—HTR2A—sympathetic nervous system—Parkinson's disease	0.003	0.0389	CbGeAlD
Acepromazine—DRD1—nerve—Parkinson's disease	0.00291	0.0377	CbGeAlD
Acepromazine—DRD2—telencephalic ventricle—Parkinson's disease	0.00272	0.0353	CbGeAlD
Acepromazine—HTR2A—pons—Parkinson's disease	0.00218	0.0283	CbGeAlD
Acepromazine—HTR2A—autonomic nervous system—Parkinson's disease	0.00201	0.0261	CbGeAlD
Acepromazine—HTR2A—telencephalic ventricle—Parkinson's disease	0.0018	0.0233	CbGeAlD
Acepromazine—DRD2—nerve—Parkinson's disease	0.00172	0.0223	CbGeAlD
Acepromazine—HTR2A—peripheral nervous system—Parkinson's disease	0.00145	0.0188	CbGeAlD
Acepromazine—HTR1A—hindbrain—Parkinson's disease	0.00142	0.0185	CbGeAlD
Acepromazine—ADRA1A—hindbrain—Parkinson's disease	0.00131	0.017	CbGeAlD
Acepromazine—DRD2—hindbrain—Parkinson's disease	0.00129	0.0167	CbGeAlD
Acepromazine—DRD1—brainstem—Parkinson's disease	0.00125	0.0162	CbGeAlD
Acepromazine—DRD1—forebrain—Parkinson's disease	0.0012	0.0156	CbGeAlD
Acepromazine—HTR2A—nerve—Parkinson's disease	0.00113	0.0147	CbGeAlD
Acepromazine—SLC22A1—forebrain—Parkinson's disease	0.000953	0.0124	CbGeAlD
Acepromazine—HTR2A—hindbrain—Parkinson's disease	0.000848	0.011	CbGeAlD
Acepromazine—HTR1A—brainstem—Parkinson's disease	0.000816	0.0106	CbGeAlD
Acepromazine—DRD1—midbrain—Parkinson's disease	0.000795	0.0103	CbGeAlD
Acepromazine—HTR1A—forebrain—Parkinson's disease	0.000787	0.0102	CbGeAlD
Acepromazine—ADRA1A—brainstem—Parkinson's disease	0.000752	0.00975	CbGeAlD
Acepromazine—ADRA1B—head—Parkinson's disease	0.00074	0.00959	CbGeAlD
Acepromazine—DRD2—brainstem—Parkinson's disease	0.000737	0.00956	CbGeAlD
Acepromazine—ADRA1A—forebrain—Parkinson's disease	0.000726	0.00941	CbGeAlD
Acepromazine—DRD2—forebrain—Parkinson's disease	0.000711	0.00923	CbGeAlD
Acepromazine—ADRA1B—nervous system—Parkinson's disease	0.000701	0.0091	CbGeAlD
Acepromazine—DRD1—head—Parkinson's disease	0.00069	0.00894	CbGeAlD
Acepromazine—ADRA1B—central nervous system—Parkinson's disease	0.000675	0.00876	CbGeAlD
Acepromazine—HTR1A—cardiovascular system—Parkinson's disease	0.000666	0.00864	CbGeAlD
Acepromazine—DRD1—nervous system—Parkinson's disease	0.000654	0.00848	CbGeAlD
Acepromazine—DRD1—central nervous system—Parkinson's disease	0.000629	0.00816	CbGeAlD
Acepromazine—ADRA1A—cardiovascular system—Parkinson's disease	0.000614	0.00796	CbGeAlD
Acepromazine—SLC22A1—head—Parkinson's disease	0.000546	0.00708	CbGeAlD
Acepromazine—ADRA1B—brain—Parkinson's disease	0.000536	0.00695	CbGeAlD
Acepromazine—HTR2A—embryo—Parkinson's disease	0.000531	0.00688	CbGeAlD
Acepromazine—HTR1A—midbrain—Parkinson's disease	0.00052	0.00674	CbGeAlD
Acepromazine—SLC22A1—nervous system—Parkinson's disease	0.000518	0.00671	CbGeAlD
Acepromazine—HTR1A—spinal cord—Parkinson's disease	0.000507	0.00658	CbGeAlD
Acepromazine—DRD1—brain—Parkinson's disease	0.0005	0.00648	CbGeAlD
Acepromazine—SLC22A1—central nervous system—Parkinson's disease	0.000498	0.00646	CbGeAlD
Acepromazine—HTR2A—brainstem—Parkinson's disease	0.000486	0.00631	CbGeAlD
Acepromazine—DRD2—midbrain—Parkinson's disease	0.00047	0.00609	CbGeAlD
Acepromazine—HTR2A—forebrain—Parkinson's disease	0.000469	0.00609	CbGeAlD
Acepromazine—HTR1A—head—Parkinson's disease	0.000451	0.00585	CbGeAlD
Acepromazine—HTR1A—nervous system—Parkinson's disease	0.000427	0.00554	CbGeAlD
Acepromazine—ADRA1A—head—Parkinson's disease	0.000416	0.00539	CbGeAlD
Acepromazine—HTR1A—central nervous system—Parkinson's disease	0.000412	0.00534	CbGeAlD
Acepromazine—DRD2—head—Parkinson's disease	0.000407	0.00528	CbGeAlD
Acepromazine—HTR1A—cerebellum—Parkinson's disease	0.000402	0.00522	CbGeAlD
Acepromazine—HTR2A—cardiovascular system—Parkinson's disease	0.000397	0.00515	CbGeAlD
Acepromazine—SLC22A1—brain—Parkinson's disease	0.000396	0.00513	CbGeAlD
Acepromazine—ADRA1A—nervous system—Parkinson's disease	0.000394	0.00511	CbGeAlD
Acepromazine—DRD2—nervous system—Parkinson's disease	0.000386	0.00501	CbGeAlD
Acepromazine—ADRA1A—central nervous system—Parkinson's disease	0.000379	0.00492	CbGeAlD
Acepromazine—ALB—brain—Parkinson's disease	0.000379	0.00491	CbGeAlD
Acepromazine—DRD2—central nervous system—Parkinson's disease	0.000372	0.00482	CbGeAlD
Acepromazine—ADRA1A—cerebellum—Parkinson's disease	0.000371	0.00481	CbGeAlD
Acepromazine—DRD2—cerebellum—Parkinson's disease	0.000363	0.00471	CbGeAlD
Acepromazine—HTR2A—medulla oblongata—Parkinson's disease	0.000339	0.0044	CbGeAlD
Acepromazine—HTR1A—brain—Parkinson's disease	0.000327	0.00424	CbGeAlD
Acepromazine—HTR2A—midbrain—Parkinson's disease	0.00031	0.00402	CbGeAlD
Acepromazine—HTR2A—spinal cord—Parkinson's disease	0.000302	0.00392	CbGeAlD
Acepromazine—ADRA1A—brain—Parkinson's disease	0.000301	0.00391	CbGeAlD
Acepromazine—DRD2—brain—Parkinson's disease	0.000295	0.00383	CbGeAlD
Acepromazine—HTR2A—head—Parkinson's disease	0.000269	0.00348	CbGeAlD
Acepromazine—HTR2A—nervous system—Parkinson's disease	0.000255	0.0033	CbGeAlD
Acepromazine—HTR2A—central nervous system—Parkinson's disease	0.000245	0.00318	CbGeAlD
Acepromazine—HTR2A—cerebellum—Parkinson's disease	0.00024	0.00311	CbGeAlD
Acepromazine—Acetophenazine—DRD1—Parkinson's disease	0.000226	0.0283	CrCbGaD
Acepromazine—Propericiazine—DRD1—Parkinson's disease	0.0002	0.025	CrCbGaD
Acepromazine—HTR2A—brain—Parkinson's disease	0.000195	0.00253	CbGeAlD
Acepromazine—Acetophenazine—DRD2—Parkinson's disease	0.000159	0.02	CrCbGaD
Acepromazine—Triflupromazine—DRD1—Parkinson's disease	0.000139	0.0174	CrCbGaD
Acepromazine—Clomipramine—GSTP1—Parkinson's disease	0.000129	0.0162	CrCbGaD
Acepromazine—Thioproperazine—DRD1—Parkinson's disease	0.000125	0.0157	CrCbGaD
Acepromazine—Mesoridazine—DRD3—Parkinson's disease	0.000124	0.0155	CrCbGaD
Acepromazine—Thiothixene—DRD1—Parkinson's disease	0.000123	0.0155	CrCbGaD
Acepromazine—Pipotiazine—DRD1—Parkinson's disease	0.000123	0.0155	CrCbGaD
Acepromazine—Prochlorperazine—DRD3—Parkinson's disease	0.00012	0.0151	CrCbGaD
Acepromazine—Cyamemazine—HTR2A—Parkinson's disease	0.000109	0.0136	CrCbGaD
Acepromazine—Fluphenazine—DRD3—Parkinson's disease	0.000109	0.0136	CrCbGaD
Acepromazine—Fluphenazine—DRD1—Parkinson's disease	0.000107	0.0134	CrCbGaD
Acepromazine—Thioproperazine—HTR1A—Parkinson's disease	0.000104	0.013	CrCbGaD
Acepromazine—Propiomazine—DRD1—Parkinson's disease	0.000103	0.0129	CrCbGaD
Acepromazine—Thiothixene—HTR1A—Parkinson's disease	0.000102	0.0128	CrCbGaD
Acepromazine—Pipotiazine—HTR1A—Parkinson's disease	0.000102	0.0128	CrCbGaD
Acepromazine—Mesoridazine—HTR1A—Parkinson's disease	0.000101	0.0127	CrCbGaD
Acepromazine—Thioridazine—HTR7—Parkinson's disease	9.96e-05	0.0125	CrCbGaD
Acepromazine—Chlorprothixene—DRD3—Parkinson's disease	9.89e-05	0.0124	CrCbGaD
Acepromazine—Triflupromazine—DRD2—Parkinson's disease	9.78e-05	0.0122	CrCbGaD
Acepromazine—Chlorprothixene—DRD1—Parkinson's disease	9.71e-05	0.0122	CrCbGaD
Acepromazine—Thioridazine—DRD1—Parkinson's disease	9.19e-05	0.0115	CrCbGaD
Acepromazine—Perphenazine—HTR7—Parkinson's disease	9.14e-05	0.0114	CrCbGaD
Acepromazine—Methotrimeprazine—DRD3—Parkinson's disease	8.94e-05	0.0112	CrCbGaD
Acepromazine—Fluphenazine—HTR1A—Parkinson's disease	8.86e-05	0.0111	CrCbGaD
Acepromazine—Thioproperazine—DRD2—Parkinson's disease	8.84e-05	0.0111	CrCbGaD
Acepromazine—Methotrimeprazine—DRD1—Parkinson's disease	8.77e-05	0.011	CrCbGaD
Acepromazine—Pipotiazine—DRD2—Parkinson's disease	8.7e-05	0.0109	CrCbGaD
Acepromazine—Thiothixene—DRD2—Parkinson's disease	8.7e-05	0.0109	CrCbGaD
Acepromazine—Mequitazine—CYP2D6—Parkinson's disease	8.64e-05	0.0108	CrCbGaD
Acepromazine—Mesoridazine—DRD2—Parkinson's disease	8.59e-05	0.0108	CrCbGaD
Acepromazine—Trimipramine—SLC6A3—Parkinson's disease	8.51e-05	0.0107	CrCbGaD
Acepromazine—Perphenazine—DRD1—Parkinson's disease	8.43e-05	0.0106	CrCbGaD
Acepromazine—Prochlorperazine—DRD2—Parkinson's disease	8.31e-05	0.0104	CrCbGaD
Acepromazine—Diltiazem—CYP2D6—Parkinson's disease	7.75e-05	0.00971	CrCbGaD
Acepromazine—Thioridazine—HTR1A—Parkinson's disease	7.63e-05	0.00956	CrCbGaD
Acepromazine—Promazine—DRD1—Parkinson's disease	7.6e-05	0.00952	CrCbGaD
Acepromazine—Fluphenazine—DRD2—Parkinson's disease	7.52e-05	0.00942	CrCbGaD
Acepromazine—Trimipramine—HTR1A—Parkinson's disease	7.45e-05	0.00934	CrCbGaD
Acepromazine—Desipramine—SLC6A3—Parkinson's disease	7.44e-05	0.00932	CrCbGaD
Acepromazine—Chlorpromazine—HTR7—Parkinson's disease	7.25e-05	0.00908	CrCbGaD
Acepromazine—Fluphenazine—CYP2E1—Parkinson's disease	7.24e-05	0.00907	CrCbGaD
Acepromazine—Propiomazine—DRD2—Parkinson's disease	7.23e-05	0.00906	CrCbGaD
Acepromazine—Imipramine—HTR7—Parkinson's disease	7.21e-05	0.00903	CrCbGaD
Acepromazine—Trifluoperazine—HTR1A—Parkinson's disease	7.08e-05	0.00887	CrCbGaD
Acepromazine—Perphenazine—HTR1A—Parkinson's disease	7e-05	0.00877	CrCbGaD
Acepromazine—Chlorprothixene—DRD2—Parkinson's disease	6.85e-05	0.00858	CrCbGaD
Acepromazine—Thioproperazine—HTR2A—Parkinson's disease	6.83e-05	0.00856	CrCbGaD
Acepromazine—Chlorpromazine—DRD3—Parkinson's disease	6.82e-05	0.00854	CrCbGaD
Acepromazine—Thiothixene—HTR2A—Parkinson's disease	6.72e-05	0.00842	CrCbGaD
Acepromazine—Pipotiazine—HTR2A—Parkinson's disease	6.72e-05	0.00842	CrCbGaD
Acepromazine—Chlorpromazine—DRD1—Parkinson's disease	6.69e-05	0.00838	CrCbGaD
Acepromazine—Mesoridazine—HTR2A—Parkinson's disease	6.64e-05	0.00831	CrCbGaD
Acepromazine—Desipramine—HTR1A—Parkinson's disease	6.52e-05	0.00816	CrCbGaD
Acepromazine—Thioridazine—DRD2—Parkinson's disease	6.48e-05	0.00811	CrCbGaD
Acepromazine—Trimipramine—DRD2—Parkinson's disease	6.33e-05	0.00793	CrCbGaD
Acepromazine—Imipramine—SLC6A3—Parkinson's disease	6.31e-05	0.0079	CrCbGaD
Acepromazine—Thioridazine—CYP2E1—Parkinson's disease	6.24e-05	0.00781	CrCbGaD
Acepromazine—Methotrimeprazine—DRD2—Parkinson's disease	6.18e-05	0.00775	CrCbGaD
Acepromazine—Thiothixene—CYP2D6—Parkinson's disease	6.15e-05	0.0077	CrCbGaD
Acepromazine—Pipotiazine—CYP2D6—Parkinson's disease	6.15e-05	0.0077	CrCbGaD
Acepromazine—Promethazine—DRD2—Parkinson's disease	6.09e-05	0.00763	CrCbGaD
Acepromazine—Mesoridazine—CYP2D6—Parkinson's disease	6.07e-05	0.0076	CrCbGaD
Acepromazine—Trifluoperazine—DRD2—Parkinson's disease	6.01e-05	0.00753	CrCbGaD
Acepromazine—Methotrimeprazine—CYP2E1—Parkinson's disease	5.95e-05	0.00746	CrCbGaD
Acepromazine—Perphenazine—DRD2—Parkinson's disease	5.95e-05	0.00745	CrCbGaD
Acepromazine—Prochlorperazine—CYP2D6—Parkinson's disease	5.88e-05	0.00736	CrCbGaD
Acepromazine—Fluphenazine—HTR2A—Parkinson's disease	5.81e-05	0.00728	CrCbGaD
Acepromazine—Propiomazine—HTR2A—Parkinson's disease	5.59e-05	0.007	CrCbGaD
Acepromazine—Chlorpromazine—HTR1A—Parkinson's disease	5.56e-05	0.00696	CrCbGaD
Acepromazine—Diltiazem—ABCB1—Parkinson's disease	5.54e-05	0.00693	CrCbGaD
Acepromazine—Desipramine—DRD2—Parkinson's disease	5.53e-05	0.00693	CrCbGaD
Acepromazine—Imipramine—HTR1A—Parkinson's disease	5.53e-05	0.00692	CrCbGaD
Acepromazine—Promazine—DRD2—Parkinson's disease	5.36e-05	0.00671	CrCbGaD
Acepromazine—Desipramine—CYP2E1—Parkinson's disease	5.33e-05	0.00667	CrCbGaD
Acepromazine—Clomipramine—HTR2A—Parkinson's disease	5.31e-05	0.00666	CrCbGaD
Acepromazine—Fluphenazine—CYP2D6—Parkinson's disease	5.31e-05	0.00666	CrCbGaD
Acepromazine—Chlorprothixene—HTR2A—Parkinson's disease	5.29e-05	0.00663	CrCbGaD
Acepromazine—Thioridazine—HTR2A—Parkinson's disease	5.01e-05	0.00627	CrCbGaD
Acepromazine—Triflupromazine—ABCB1—Parkinson's disease	4.93e-05	0.00618	CrCbGaD
Acepromazine—Trimipramine—HTR2A—Parkinson's disease	4.89e-05	0.00612	CrCbGaD
Acepromazine—Clomipramine—CYP2D6—Parkinson's disease	4.86e-05	0.00609	CrCbGaD
Acepromazine—Methotrimeprazine—HTR2A—Parkinson's disease	4.78e-05	0.00599	CrCbGaD
Acepromazine—Chlorpromazine—DRD2—Parkinson's disease	4.72e-05	0.00591	CrCbGaD
Acepromazine—Promethazine—HTR2A—Parkinson's disease	4.71e-05	0.0059	CrCbGaD
Acepromazine—Imipramine—DRD2—Parkinson's disease	4.69e-05	0.00588	CrCbGaD
Acepromazine—Trifluoperazine—HTR2A—Parkinson's disease	4.64e-05	0.00582	CrCbGaD
Acepromazine—Perphenazine—HTR2A—Parkinson's disease	4.59e-05	0.00576	CrCbGaD
Acepromazine—Thioridazine—CYP2D6—Parkinson's disease	4.58e-05	0.00573	CrCbGaD
Acepromazine—Chlorpromazine—CYP2E1—Parkinson's disease	4.54e-05	0.00569	CrCbGaD
Acepromazine—Imipramine—CYP2E1—Parkinson's disease	4.52e-05	0.00566	CrCbGaD
Acepromazine—Trimipramine—CYP2D6—Parkinson's disease	4.47e-05	0.0056	CrCbGaD
Acepromazine—Methotrimeprazine—CYP2D6—Parkinson's disease	4.37e-05	0.00547	CrCbGaD
Acepromazine—Promethazine—CYP2D6—Parkinson's disease	4.31e-05	0.00539	CrCbGaD
Acepromazine—Desipramine—HTR2A—Parkinson's disease	4.28e-05	0.00536	CrCbGaD
Acepromazine—Perphenazine—CYP2D6—Parkinson's disease	4.2e-05	0.00526	CrCbGaD
Acepromazine—Promazine—HTR2A—Parkinson's disease	4.14e-05	0.00519	CrCbGaD
Acepromazine—Desipramine—CYP2D6—Parkinson's disease	3.91e-05	0.0049	CrCbGaD
Acepromazine—Fluphenazine—ABCB1—Parkinson's disease	3.79e-05	0.00475	CrCbGaD
Acepromazine—Chlorpromazine—HTR2A—Parkinson's disease	3.64e-05	0.00457	CrCbGaD
Acepromazine—Imipramine—HTR2A—Parkinson's disease	3.63e-05	0.00454	CrCbGaD
Acepromazine—Clomipramine—ABCB1—Parkinson's disease	3.47e-05	0.00435	CrCbGaD
Acepromazine—Chlorprothixene—ABCB1—Parkinson's disease	3.45e-05	0.00433	CrCbGaD
Acepromazine—Chlorpromazine—CYP2D6—Parkinson's disease	3.33e-05	0.00418	CrCbGaD
Acepromazine—Imipramine—CYP2D6—Parkinson's disease	3.32e-05	0.00415	CrCbGaD
Acepromazine—Trimipramine—ABCB1—Parkinson's disease	3.19e-05	0.004	CrCbGaD
Acepromazine—Promethazine—ABCB1—Parkinson's disease	3.07e-05	0.00385	CrCbGaD
Acepromazine—Trifluoperazine—ABCB1—Parkinson's disease	3.03e-05	0.0038	CrCbGaD
Acepromazine—Desipramine—ABCB1—Parkinson's disease	2.79e-05	0.0035	CrCbGaD
Acepromazine—DRD2—Signaling by GPCR—DRD1—Parkinson's disease	2.54e-05	0.000246	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.54e-05	0.000245	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.54e-05	0.000245	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	2.54e-05	0.000245	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.53e-05	0.000245	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	2.52e-05	0.000244	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	2.5e-05	0.000242	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	2.5e-05	0.000241	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—ADRBK1—Parkinson's disease	2.49e-05	0.000241	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.49e-05	0.000241	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PENK—Parkinson's disease	2.48e-05	0.00024	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAG—Parkinson's disease	2.48e-05	0.00024	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD3—Parkinson's disease	2.46e-05	0.000238	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—PDYN—Parkinson's disease	2.46e-05	0.000238	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HTR7—Parkinson's disease	2.45e-05	0.000237	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	2.45e-05	0.000237	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—FGF20—Parkinson's disease	2.45e-05	0.000237	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.44e-05	0.000236	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAG—Parkinson's disease	2.44e-05	0.000236	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PENK—Parkinson's disease	2.44e-05	0.000236	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	2.43e-05	0.000235	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	2.42e-05	0.000234	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—SOD1—Parkinson's disease	2.42e-05	0.000234	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HTR7—Parkinson's disease	2.41e-05	0.000233	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD2—Parkinson's disease	2.41e-05	0.000233	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	2.41e-05	0.000233	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	2.41e-05	0.000233	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	2.41e-05	0.000233	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	2.4e-05	0.000232	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	2.39e-05	0.000231	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	2.39e-05	0.000231	CbGpPWpGaD
Acepromazine—Chlorpromazine—ABCB1—Parkinson's disease	2.38e-05	0.00298	CrCbGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.38e-05	0.00023	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ADORA2A—Parkinson's disease	2.37e-05	0.000229	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	2.37e-05	0.000229	CbGpPWpGaD
Acepromazine—Imipramine—ABCB1—Parkinson's disease	2.37e-05	0.00297	CrCbGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	2.36e-05	0.000228	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	2.36e-05	0.000228	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—EDN1—Parkinson's disease	2.36e-05	0.000228	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	2.32e-05	0.000224	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	2.31e-05	0.000223	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—ABL1—Parkinson's disease	2.31e-05	0.000223	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—ADRBK1—Parkinson's disease	2.3e-05	0.000222	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—IGF2—Parkinson's disease	2.3e-05	0.000222	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	2.29e-05	0.000221	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—HTR2A—Parkinson's disease	2.27e-05	0.00022	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—PDYN—Parkinson's disease	2.27e-05	0.000219	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.26e-05	0.000219	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	2.24e-05	0.000216	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	2.23e-05	0.000216	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HTR7—Parkinson's disease	2.23e-05	0.000215	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.21e-05	0.000214	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	2.19e-05	0.000212	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	2.19e-05	0.000212	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—INSR—Parkinson's disease	2.19e-05	0.000212	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	2.18e-05	0.000211	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—HGF—Parkinson's disease	2.17e-05	0.00021	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	2.14e-05	0.000207	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	2.14e-05	0.000207	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GFAP—Parkinson's disease	2.13e-05	0.000206	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	2.13e-05	0.000206	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—GRM5—Parkinson's disease	2.11e-05	0.000204	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	2.1e-05	0.000203	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	2.1e-05	0.000203	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	2.07e-05	0.0002	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—FGB—Parkinson's disease	2.07e-05	0.0002	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HTR2A—Parkinson's disease	2.07e-05	0.0002	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR1A—Parkinson's disease	2.06e-05	0.000199	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	2.05e-05	0.000199	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	2.04e-05	0.000197	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	2.03e-05	0.000196	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	2.03e-05	0.000196	CbGpPWpGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.03e-05	0.000196	CbGpPWpGaD
Acepromazine—ALB—Metabolism—DDC—Parkinson's disease	2.03e-05	0.000196	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—TAC1—Parkinson's disease	2.03e-05	0.000196	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.01e-05	0.000195	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	2e-05	0.000194	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—IL6—Parkinson's disease	1.97e-05	0.000191	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—EDN1—Parkinson's disease	1.96e-05	0.00019	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.96e-05	0.000189	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	1.94e-05	0.000188	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	1.93e-05	0.000187	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	1.93e-05	0.000187	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.93e-05	0.000187	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD3—Parkinson's disease	1.93e-05	0.000186	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GSTA4—Parkinson's disease	1.92e-05	0.000185	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CYP2D6—Parkinson's disease	1.9e-05	0.000183	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	1.89e-05	0.000183	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.89e-05	0.000183	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.88e-05	0.000182	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	1.86e-05	0.00018	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CTGF—Parkinson's disease	1.86e-05	0.00018	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FGF20—Parkinson's disease	1.85e-05	0.000179	CbGpPWpGaD
Acepromazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.84e-05	0.000178	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	1.82e-05	0.000176	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.8e-05	0.000174	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—ADRBK1—Parkinson's disease	1.8e-05	0.000174	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	1.79e-05	0.000173	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADORA2A—Parkinson's disease	1.79e-05	0.000173	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—EDN1—Parkinson's disease	1.78e-05	0.000172	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	1.78e-05	0.000172	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.78e-05	0.000172	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.78e-05	0.000172	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.76e-05	0.00017	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	1.75e-05	0.00017	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.74e-05	0.000169	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD2—Parkinson's disease	1.74e-05	0.000168	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR7—Parkinson's disease	1.74e-05	0.000168	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CYP2E1—Parkinson's disease	1.73e-05	0.000168	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.73e-05	0.000167	CbGpPWpGaD
Acepromazine—ALB—Metabolism—PLA2G6—Parkinson's disease	1.72e-05	0.000167	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	1.72e-05	0.000166	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.72e-05	0.000166	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—NQO1—Parkinson's disease	1.72e-05	0.000166	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.71e-05	0.000165	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MAOB—Parkinson's disease	1.71e-05	0.000165	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	1.7e-05	0.000164	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	1.69e-05	0.000164	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—TH—Parkinson's disease	1.69e-05	0.000163	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	1.69e-05	0.000163	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	1.66e-05	0.000161	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.66e-05	0.00016	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.65e-05	0.00016	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.65e-05	0.00016	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	1.63e-05	0.000157	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.63e-05	0.000157	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.62e-05	0.000157	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CYCS—Parkinson's disease	1.62e-05	0.000157	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	1.59e-05	0.000154	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	1.58e-05	0.000152	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.56e-05	0.000151	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.56e-05	0.000151	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.55e-05	0.00015	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.55e-05	0.00015	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.54e-05	0.000149	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.53e-05	0.000148	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.53e-05	0.000148	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.51e-05	0.000146	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	1.51e-05	0.000146	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.5e-05	0.000145	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.5e-05	0.000145	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	1.5e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.5e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.5e-05	0.000145	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.48e-05	0.000143	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	1.48e-05	0.000143	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	1.47e-05	0.000142	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IGF2—Parkinson's disease	1.46e-05	0.000141	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.45e-05	0.000141	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	1.45e-05	0.00014	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—COMT—Parkinson's disease	1.44e-05	0.000139	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.43e-05	0.000138	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GSTP1—Parkinson's disease	1.43e-05	0.000138	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MAOA—Parkinson's disease	1.43e-05	0.000138	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	1.43e-05	0.000138	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	1.43e-05	0.000138	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	1.41e-05	0.000136	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—HMOX1—Parkinson's disease	1.41e-05	0.000136	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	1.4e-05	0.000135	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EDN1—Parkinson's disease	1.39e-05	0.000135	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	1.36e-05	0.000131	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—ABCB1—Parkinson's disease	1.35e-05	0.000131	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.34e-05	0.000129	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR7—Parkinson's disease	1.32e-05	0.000127	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GSTM1—Parkinson's disease	1.31e-05	0.000127	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.31e-05	0.000126	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.29e-05	0.000125	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.29e-05	0.000125	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—NGF—Parkinson's disease	1.28e-05	0.000124	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP2D6—Parkinson's disease	1.27e-05	0.000123	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	1.27e-05	0.000122	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	1.27e-05	0.000122	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—GPX1—Parkinson's disease	1.26e-05	0.000122	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.26e-05	0.000121	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CTGF—Parkinson's disease	1.25e-05	0.00012	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	1.22e-05	0.000118	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	1.21e-05	0.000117	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	1.2e-05	0.000116	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	1.2e-05	0.000116	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MTHFR—Parkinson's disease	1.16e-05	0.000112	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYP2E1—Parkinson's disease	1.16e-05	0.000112	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	1.16e-05	0.000112	CbGpPWpGaD
Acepromazine—ALB—Metabolism—NQO1—Parkinson's disease	1.15e-05	0.000111	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	1.14e-05	0.00011	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—APOE—Parkinson's disease	1.13e-05	0.00011	CbGpPWpGaD
Acepromazine—ALB—Metabolism—TH—Parkinson's disease	1.13e-05	0.000109	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF2—Parkinson's disease	1.1e-05	0.000107	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—NGF—Parkinson's disease	1.1e-05	0.000107	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CYCS—Parkinson's disease	1.09e-05	0.000105	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	1.08e-05	0.000105	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—APOE—Parkinson's disease	1.08e-05	0.000105	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	1.07e-05	0.000103	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	1.06e-05	0.000103	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EDN1—Parkinson's disease	1.05e-05	0.000102	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	1.05e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	1.05e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	1.05e-05	0.000101	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	1.04e-05	0.0001	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	1.03e-05	9.92e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	1.01e-05	9.81e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	9.99e-06	9.66e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—APOE—Parkinson's disease	9.75e-06	9.43e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—INS—Parkinson's disease	9.69e-06	9.37e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—NGF—Parkinson's disease	9.68e-06	9.35e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—COMT—Parkinson's disease	9.61e-06	9.29e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GSTP1—Parkinson's disease	9.57e-06	9.25e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MAOA—Parkinson's disease	9.55e-06	9.23e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	9.52e-06	9.2e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—HMOX1—Parkinson's disease	9.44e-06	9.12e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	9.32e-06	9.01e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	9.29e-06	8.98e-05	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—INS—Parkinson's disease	9.24e-06	8.93e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	9.21e-06	8.9e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—ABCB1—Parkinson's disease	9.06e-06	8.76e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	8.87e-06	8.58e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GSTM1—Parkinson's disease	8.79e-06	8.5e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—APOE—Parkinson's disease	8.56e-06	8.28e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	8.43e-06	8.15e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—GPX1—Parkinson's disease	8.42e-06	8.14e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—INS—Parkinson's disease	8.33e-06	8.06e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	8.25e-06	7.98e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	7.94e-06	7.67e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MTHFR—Parkinson's disease	7.77e-06	7.51e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—INS—Parkinson's disease	7.32e-06	7.07e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—APOE—Parkinson's disease	7.24e-06	6.99e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CASP3—Parkinson's disease	7.21e-06	6.97e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—INS—Parkinson's disease	7.2e-06	6.96e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—IL6—Parkinson's disease	7.17e-06	6.93e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	7.05e-06	6.81e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	6.63e-06	6.41e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	6.2e-06	6e-05	CbGpPWpGaD
Acepromazine—ALB—Metabolism—INS—Parkinson's disease	6.18e-06	5.98e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	6.16e-06	5.96e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	5.91e-06	5.71e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	5.87e-06	5.67e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	5.7e-06	5.51e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CASP3—Parkinson's disease	5.45e-06	5.27e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	5.43e-06	5.25e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—IL6—Parkinson's disease	5.41e-06	5.23e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	5.36e-06	5.18e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	5.32e-06	5.15e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	5.25e-06	5.07e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	5.21e-06	5.04e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	5.01e-06	4.84e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	4.93e-06	4.76e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	4.82e-06	4.66e-05	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—IL6—Parkinson's disease	4.23e-06	4.09e-05	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—IL6—Parkinson's disease	3.64e-06	3.52e-05	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	3.47e-06	3.35e-05	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—IL6—Parkinson's disease	3.2e-06	3.09e-05	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	3.15e-06	3.04e-05	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	3.08e-06	2.98e-05	CbGpPWpGaD
